Therapy For ALL
Poor prognosis indicators for ALL
>30
years of age
WBC
>30.0 x 109/L
Common Childhood ALL:
Cure
rate:
>80%
of cases cured (>4 years in remission)
Remission
rate:
70-90%
Adult ALL:
Long
time survival:
25-50%
Extramedullary
hematopoiesis
L3
type blasts (Burkitt)
Chromosomal
abnormalities
>6
weeks of induction therapy required